<DOC>
	<DOCNO>NCT00898794</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn effect bevacizumab VEGF platelet cluster . PURPOSE : This research study look effect bevacizumab VEGF platelet cluster patient cancer receive bevacizumab .</brief_summary>
	<brief_title>Effect Bevacizumab VEGF Platelet Clustering Patients Who Are Receiving Bevacizumab Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine influence bevacizumab platelet aggregation patient receive bevacizumab cancer . - To determine influence VEGF platelet aggregation . - To determine influence VEGF bevacizumab cyclooxygenesis . - To determine sequence medication play role platelet aggregation . OUTLINE : Blood sample collect bevacizumab infusion . Samples analyze measurement platelet aggregation , coagulation parameter , endothelial activation ( e.g. , fibrin fragment F1 2 , thrombin antithrombin complex , soluble P-selectin , Von Willebrand factor factor VIII , tissue factor , endothelin 1 ) .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Receiving bevacizumab cancer PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
</DOC>